Justin J. File Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Justin J. File.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Justin J. File. Justin J. File is Chief Financial Officer in Evofem Biosciences, Inc. ($NEOT).
Latest Insider Trading Transactions of Justin J. File
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Buy | P | 1.03 | 24,500 | 25,235 | 440,388 | 415.9 K to 440.4 K (+5.89 %) |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 3.25 | 150,000 | 487,500 | 150,000 | |
| Feb 03 2021 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 200,000 | 0 | 458,168 | 258.2 K to 458.2 K (+77.47 %) |
| Nov 18 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Buy | P | 2.17 | 7,760 | 16,839 | 258,168 | 250.4 K to 258.2 K (+3.10 %) |
| Jun 15 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Buy | P | 3.14 | 8,500 | 26,690 | 250,408 | 241.9 K to 250.4 K (+3.51 %) |
| Jun 08 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 3.31 | 42,810 | 141,701 | 237,605 | 280.4 K to 237.6 K (-15.27 %) |
| May 26 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 4.99 | 42,262 | 210,887 | 280,415 | 322.7 K to 280.4 K (-13.10 %) |
| May 08 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 5.24 | 8,420 | 44,121 | 322,677 | 331.1 K to 322.7 K (-2.54 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 4.87 | 100,000 | 487,000 | 100,000 | |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 150,000 | 0 | 331,097 | 181.1 K to 331.1 K (+82.83 %) |
| Feb 07 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 5.21 | 3,846 | 20,038 | 181,097 | 177.3 K to 181.1 K (+2.17 %) |
| Jan 15 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Sell | S | 6.00 | 1,648 | 9,888 | 177,251 | 178.9 K to 177.3 K (-0.92 %) |
| Jan 06 2020 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Sell | S | 6.05 | 3,352 | 20,280 | 178,899 | 182.3 K to 178.9 K (-1.84 %) |
| Dec 04 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Sell | S | 7.16 | 10,000 | 71,600 | 182,251 | 192.3 K to 182.3 K (-5.20 %) |
| Nov 26 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 6.22 | 10,102 | 62,834 | 192,251 | 202.4 K to 192.3 K (-4.99 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Sell | S | 6.00 | 4,900 | 29,400 | 202,353 | 207.3 K to 202.4 K (-2.36 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Sell | S | 6.00 | 100 | 600 | 207,253 | 207.4 K to 207.3 K (-0.05 %) |
| Nov 21 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 5.74 | 10,102 | 57,985 | 207,353 | 217.5 K to 207.4 K (-4.65 %) |
| Aug 26 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 5.13 | 1,558 | 7,993 | 217,455 | 219 K to 217.5 K (-0.71 %) |
| Jun 12 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 6.36 | 10,185 | 64,777 | 219,013 | 229.2 K to 219 K (-4.44 %) |
| Apr 03 2019 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 3.55 | 1,292 | 4,587 | 229,198 | 230.5 K to 229.2 K (-0.56 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Payment of Exercise | F | 2.46 | 119,510 | 293,995 | 180,490 | 300 K to 180.5 K (-39.84 %) |
| Jul 03 2018 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Mar 14 2018 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 7.29 | 300,000 | 2,187,000 | 300,000 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 46.36 | 10,266 | 475,932 | 10,266 | |
| Jan 18 2018 | NEOT | Evofem Biosciences ... | File Justin J. | Chief Financial Off ... | Option Exercise | A | 46.36 | 12,833 | 594,938 | 12,833 |
Page: 1